Dec 02, 2020
1:250
For every 250 shares held, investors received 1. The price per share adjusted from $0.00 to $0.93.
The split itself did not change the total investment value.
CYduct Diagnostics Inc. (OTC:CYDX) operates in the Medical specialties industry.
CYduct Diagnostics Inc. company overviewCYduct Diagnostics Inc.'s most recent stock split was on December 2, 2020. It was a 1-for-250 reverse split, so shareholders received 1 share for every 250 they held.
CYduct Diagnostics Inc. (OTC:CYDX) has split its stock 5 times: a 1-for-100 reverse split on January 16, 2007, a 1-for-5000 reverse split on May 29, 2008, a 1-for-2000 reverse split on November 24, 2010, a 1-for-1500 reverse split on September 30, 2015, and a 1-for-250 reverse split on December 2, 2020.
CYduct Diagnostics Inc. has split its stock 5 times. This history records 5 reverse splits between January 16, 2007 and December 2, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In CYduct Diagnostics Inc.'s 1-for-250 reverse split on December 2, 2020, every 250 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
CYduct Diagnostics Inc. has not announced a new split in our records. Its most recent split was on December 2, 2020, 5 years ago. Companies announce splits in advance, and any new OTC:CYDX split will appear on this page.